FROM NURSE, TO ROLES IN MEDTECH MARKETING, CHAMPIONING WOMEN’S HEALTH
With
Aggie Cox
Government Affairs & Marketing Director – ANZ, Hologic
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | July 2026
Aggie Cox is a senior healthcare marketing leader and women’s health advocate with over two decades of experience spanning clinical care, medical technology, and executive marketing leadership. She currently serves as Government Affairs & Marketing Director for Australia and New Zealand at Hologic, Inc., a global medical technology company dedicated to advancing women’s health through early detection, diagnosis, and treatment.
With an early career as a Registered Nurse, including frontline experience in emergency and trauma care, Aggie brings a rare clinical lens to health leadership—grounding strategy, communication, and advocacy in real patient needs. This foundation has shaped her work in ensuring women’s health messaging is evidence‑based, accessible, and designed to drive real‑world outcomes.
At Hologic, Aggie has been instrumental in elevating attention to under‑recognised and under‑treated women’s health issues, including preventive screening, sexual and reproductive health, and heavy menstrual bleeding. Her leadership has helped normalise conversations often avoided due to stigma, empowering women to seek information, diagnosis, and care earlier.
Aggie is particularly recognised for reframing marketing as a public health lever, not just a commercial function. Her work connects education, awareness, digital innovation, and clinical credibility to improve health literacy and engagement—especially among women who may delay care due to embarrassment, lack of access, or misinformation.
Aggie regularly contributes to national leadership forums, industry conferences, and community events, including International Women’s Day panels and major marketing and customer experience conferences. Her speaking focuses on the intersection of women’s health, leadership, workplace wellbeing, and purpose‑led growth, as well as resilience and non‑linear career pathways for women in leadership.
Aggie holds a Master of Marketing from Melbourne Business School and is widely respected for bridging commercial performance with social impact. She is passionate about making women’s health visible, discussable, and actionable—in healthcare systems, workplaces, and society at large.
Source: Supplied
-
Reflections from the unstoppable giant in wound care
Professor Dr.Geoff Sussman holds a position in the Faculty of Medicine, Nursing and Health Sciences Monash University, and is the Adjunct Professor of Wound Care He is a wound consultant at the Wound Clinic Austin Hospital.
-
New bar for cosmetic plastic surgeon accreditation
Population screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations.
In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’.
-
Developing the nation’s first Health and Medical Research Strategy
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.
